Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Immunol. 2022 Mar 18;208(7):1813–1827. doi: 10.4049/jimmunol.2100700

Figure 1. Maximum Number of Validated Immunogenic Mutations Identified by the Overlap of Strelka and GATK Mutect2.

Figure 1.

Comparison of the number of neoantigens derived from single nucleotide variants (SNVs) and small insertions and deletions (indels) by each of three different programs (Varscan2, GATK Mutect2, and Strelka) in the TESLA consortium dataset. Red dots represent the validated immunogenic neoantigens from each patient. The small circle represents validated immunogenic neoantigens that were not identified by the three programs.